Guizhou Yibai Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 683.8 million compared to CNY 687.87 million a year ago. Revenue was CNY 683.8 million compared to CNY 687.87 million a year ago.

Net income was CNY 44 million compared to CNY 50.55 million a year ago. Basic earnings per share from continuing operations was CNY 0.056 compared to CNY 0.064 a year ago. Diluted earnings per share from continuing operations was CNY 0.056 compared to CNY 0.064 a year ago.